Marijuana raises your blood pressure and reduces your longevity. So says this Georgia State University study, and that absolutely floors me. Nonetheless, I think it’s conclusions are worth considering — at the least, don’t smoke (or chew or in other ways imbibe) marijuana any more than you feel is necessary.

People who smoke marijuana have a three times greater risk of dying from hypertension, or high blood pressure, than those who have never used the drug, scientists said on Wednesday. The risk grows with every year of use.

Cancer remains a confounding and deadly enemy. There’s evidence, albeit sketchy, that radically cutting carbs and regular fasting will help you avoid cancer, fight cancer, and possibly live longer.

(The linked article strikes me as long-winded cheerleading. Read it if you wish.)

Boosting brain plasticity? In mice? It just might work!

Oh, and if it does, there’s clear potential for boosting brain plasticity in humans. Which may not prolong your life by much, but should make your alive years better.

Like much of the rest of the body, the brain loses flexibility with age, impacting the ability to learn, remember, and adapt. Now, scientists at University of Utah Health report they can rejuvenate the plasticity of the mouse brain, specifically in the visual cortex, increasing its ability to change in response to experience. Manipulating a single gene triggers the shift, revealing it as a potential target for new treatments that could recover the brain’s youthful potential.

Believe in God? Awesome!

Attend church regularly? Excellent!

But do not allow these to reduce your focus on staying healthy.

For religiosity, significant associations occurred between greater religiosity and higher body weight in both cross-sectional and longitudinal studies. In particular, greater religiosity was significantly associated with higher body weight in bivariate analyses but less so in multivariate analyses.


Probably personal choice.

Evidence in seven studies suggested that health behaviours and psychosocial factors mediate religion–weight relationships.

In our proprietary supplement rankings, Basis does quite well. This profile of the company behind Basis, Elysium, suggests its a deserved ranking.

Basis is clinically proven to increase NAD+ levels.


The coenzyme NAD+ has, for years, been revered as “the fountain of youth” among the bio-hacker community—mostly for its ability to improve metabolism, fight aging at the cellular level, and reduce fatigue.

Any evidence?

In the company’s first round of clinical trials, Elysium conducted a double-blind study in which 120 participants between the ages of 60-80 were divided into three groups. The first group received the recommended daily dose of Basis (250 mg of Nicotinamide Riboside and 50 mg of Pterostilbene), the second group received double the recommended daily dose, and the third group received a placebo. After just four weeks, blood tests revealed that the first group’s baseline levels of NAD+ had increased by 40 percent—and sustained that increase for the remainder of the eight-week trial. Participants taking double-doses of Basis saw a 90 percent baseline increase, also sustained.

Leave a Reply